- Hem
- Om universitetet
- Hitta person
- Sara Bjursten
Sara Bjursten
Anknuten till forskning
Avd för onkologi-
Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS
inflammation
Sara Bjursten, Zhiyuan Zhao, Hifaa Al Remawi, Marie Studahl, Ankur Pandita, Joel Simrén, Henrik Zetterberg, Anna-Carin Lundell, Anna Rudin, Lars Ny, Max Levin
EBioMedicine - 2024 -
Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition
Treatment.
Helga Björk Brynjarsdottir, Sara Bjursten, Max Levin, Inger Gjertsson, Anna Rudin
The Journal of rheumatology - 2023 -
Checkpoint inhibitor-induced adverse events in the CNS - T-cell characteristics and
biomarkers
Sara Bjursten
2023 -
Intussusceptive angiogenesis in human metastatic malignant
melanoma.
Ankur Pandita, Matias Ekstrand, Sara Bjursten, Zhiyuan Zhao, Per Fogelstrand, Kristell Le Gal, Lars Ny, Martin O Bergo, Joakim Karlsson, Jonas A Nilsson, Levent Akyürek, Malin Levin, Jan Borén, Andrew J Ewald, Keith E Mostov, Max Levin
The American Journal of Pathology - 2021 -
Early rise in brain damage markers and high ICOS expression in CD4+and CD8+T cells during checkpoint inhibitor-induced
encephalomyelitis
Sara Bjursten, Ankur Pandita, Zhiyuan Zhao, C. Frojd, Lars Ny, C. Jensen, T. Ullerstam, Henrik Jespersen, Jan Borén, Malin Levin, Henrik Zetterberg, Anna Rudin, Max Levin
Journal for Immunotherapy of Cancer - 2021 -
Dynamic ctDNA evaluation of a patient with BRAFV600E metastatic melanoma demonstrates the utility of ctDNA for disease monitoring and tumor clonality
analysis.
Christoffer Vannas, Sara Bjursten, Stefan Filges, Henrik Fagman, Anders Ståhlberg, Max Levin
Acta oncologica - 2020 -
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated
Melanoma
Sara Bjursten, Christoffer Vannas, Stefan Filges, Florian Puls, Ankur Pandita, Henrik Fagman, Anders Ståhlberg, Max Levin
Case Reports in Oncology - 2019 -
Real-world data on PD-1 inhibitor therapy in metastatic
melanoma
A. Arheden, J. Skalenius, Sara Bjursten, Ulrika Stierner, Lars Ny, Max Levin, Henrik Jespersen
Acta Oncologica - 2019 -
Checkpoint inhibitor-induced sarcoid reaction mimicking bone
metastases.
Henrik Jespersen, Sara Bjursten, Lars Ny, Max Levin
The Lancet Oncology - 2018